Abstract
Though little is known regarding the safety and efficacy of umbilical cord blood (UCB) transplantation in adults, these are increasingly used in older subjects. We compared the results of 169, ≥1-antigen mismatched UCB, 83, 1-antigen mismatched and 367, matched bone marrow (BM) transplants in patients age 16–60 years with acute and chronic leukemia. Majority of UCB recipients were mismatched at 2 loci. UCB recipients were younger, weighed less, more likely to have advanced leukemia and received a lower dose of nucleated cells.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
